VAXART INC WKN: A2JD8X ISIN: US92243A2006 Kürzel: VXRT Forum: Aktien Thema: Hauptdiskussion

Next steps Pre-clinical studies: Several studies with our S and N and S-only constructs in multiple animal models are ongoing or will begin soon, testing attributes of our vaccine candidates such as impact on infection, illness, shedding, transmission, and cross-variant protection. Clinical studies: A Phase II trial of VXA-CoV2-1, our vaccine encoding both the S and the N proteins, is expected to start mid-year 2021 instead of 2Q. The delay is due to manufacturing issues at the Baltimore contract manufacturing facility, the same facility where other COVID-19 vaccine manufacturers have also reported issues. Manufacturing of our vaccines is currently underway at the Company’s other manufacturing partner, and at our own GMP facility. We are also evaluating additional manufacturing partners both in the U.S. and abroad. Phase I/II studies of two S-only vaccine constructs targeting different variants are planned to begin in 3Q 2021. Boosting studies with previously vaccinated or infected subjects are also planned for 2H 2021. Trials in India and Latin America are expected to initiate in 2021.

As previously announced, later today Vaxart will provide new data comparing the T-cell responses induced by its VXA-CoV2-1 vaccine with those of other vaccines. The Company will also present new mucosal antibody data and review the recent Phase 1 clinical results that suggest VXA-CoV2-1 is potentially protective against new and future COVID-19 strains due to the vaccine’s more conserved target.

Vaxart Reports First Quarter 2021 Financial Results and Provides Business Update May 3, 2021 at 8:00 AM EDT

LoL😂😂😂 wird sicher wieder wie auch an Freitag aufgekauft

CYDY Be the hero to the world by approving a therapeutic that works!! Approve #leronlimab to save more lives. We’ve lost too many

Nun aber mal Gas geben

Ich denke, es dippt nochmal auf 9.50 um 15.30

🙋‍♂️

Hallo Ghul : Bin nochmal eingestiegen

Ist die Frage, wie tief es noch beim Ami dippt

https://www.globenewswire.com/news-release/2021/04/29/2219651/0/en/Vaxart-to-Present-at-the-World-Vaccine-Congress-Washington-2021.html

Richtig spannendes Unterhemen, könnte noch richtig abgehen long. Schade dass ich erst Freitag darauf aufmerksam wurde was EK betrifft, aber wenn man an steigende Kurse glaubt letztlich auch egal. Perfekten Zeitpunkt gibt's nie...

Bin sicher wir schaffe die 15€ heute. Vor 2 Monaten wurde ich ausgelacht als ich sagte Vaxart wird auf 8€ kommen schaut selbst oben nach ich jabe bei 2.88€ gekauft.

Nouviso wird sofort wieder alles aufgekauft.

750 bei 6.60

Starkes Signal wenn sofort Gegenbewegung in den Dips ist. Sah bei Microvision anders aus... 🙈⛷️